| Motus Integrative Health | |
|
1425 Eagle Ridge Dr, Schererville, IN 46375 | |
| (219) 322-6942 | |
| Not Available |
| Full Name | Motus Integrative Health |
|---|---|
| Type | Facility |
| Speciality | Chiropractor - Rehabilitation |
| Location | 1425 Eagle Ridge Dr, Schererville, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033611702 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111NR0400X | Chiropractor - Rehabilitation | 680000992A (Indiana) | Primary |
| Provider Name | Krystyna H Larson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1366505851 PECOS PAC ID: 5698777886 Enrollment ID: I20070131000462 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Christena S Wichowsky |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1083854889 PECOS PAC ID: 6709943236 Enrollment ID: I20090326000599 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Robert E Hall |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1679523104 PECOS PAC ID: 9638338536 Enrollment ID: I20120313000579 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Kelly A Oney |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689675266 PECOS PAC ID: 5395792105 Enrollment ID: I20120718000356 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Robert M Newhalfen |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1184997496 PECOS PAC ID: 1759516073 Enrollment ID: I20131022001683 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Zorn Coleman |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1205946233 PECOS PAC ID: 7113029687 Enrollment ID: I20161212000887 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Matthew E Sherwood |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1710115373 PECOS PAC ID: 7012299985 Enrollment ID: I20170130001090 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Grant Burdeau |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1275071466 PECOS PAC ID: 2668740754 Enrollment ID: I20170614000280 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Stephanie Re |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245738327 PECOS PAC ID: 4385904382 Enrollment ID: I20180213001752 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Eric S Moon |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1942200027 PECOS PAC ID: 9133018617 Enrollment ID: I20180405001834 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Adrian Gutierrez |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1962045724 PECOS PAC ID: 2466884580 Enrollment ID: I20191112000199 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Daniel T Mceowen |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1083132385 PECOS PAC ID: 6103190236 Enrollment ID: I20210322002522 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Patrick V Oliver |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1629653753 PECOS PAC ID: 5698182475 Enrollment ID: I20210323000452 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Brock Gross |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1972265122 PECOS PAC ID: 6800286063 Enrollment ID: I20211201002066 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Douglas Ryan Evenhouse |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1043756562 PECOS PAC ID: 5092078675 Enrollment ID: I20220926000412 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Provider Name | Christian Gallegos |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1811750466 PECOS PAC ID: 0244675742 Enrollment ID: I20240223002164 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Motus Integrative Health 1425 Eagle Ridge Dr, Schererville, IN 46375-1386 Ph: (219) 322-6942 | Motus Integrative Health 1425 Eagle Ridge Dr, Schererville, IN 46375 Ph: (219) 322-6942 |
News Archive
Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
Vical Incorporated today announced a new publication summarizing results from the company's completed trials of Allovectin-7 including systemic responses and an excellent safety profile in patients with metastatic melanoma.
The Healthy Home, a new book providing simple solutions for reducing toxins and other health hazards in the home, has advanced in ranking on several national best sellers lists within a month of publication. After becoming a Top 100 Amazon.com best seller following its first week of sales, The Healthy Home, released on March 22, quickly hit the New York Times, USA TODAY, Publishers Weekly and L.A. Times best sellers lists.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 1 days ago
Deboer Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2433 Ontario St Ste B, Schererville, IN 46375 Phone: 708-895-1798 | |
Northwest Indiana Chiropractic Health Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1425 Eagle Ridge Dr, Schererville, IN 46375 Phone: 219-322-6942 Fax: 219-515-2068 | |
Hayes Family Wellness Center Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 11 E Joliet St, Schererville, IN 46375 Phone: 219-661-8680 | |
Tiffany Marie Bozovich, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 221 S Rt 41, Suite B, Schererville, IN 46375 Phone: 219-322-4406 Fax: 219-322-7539 | |
Crowder Family Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 11 E Joliet St, Schererville, IN 46375 Phone: 219-864-8284 Fax: 219-864-8280 | |
Dr. Lana Louise Kaiser, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 322 E Us Highway 30, Schererville, IN 46375 Phone: 219-864-7967 Fax: 219-864-8142 |